Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
19 Jul 2024
Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR (sitagliptin and metformin hydrochloride) extended-release tablets
Source:
BSE India